ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BGMS vs ENVB // RSI-14 & 200D SMA MOMENTUM

Bio Green Med Solution Inc. (NASDAQ) VS. Enveric Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: BGMS 1 — ENVB 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BGMS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGMS VS. ENVB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BGMS ENVB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 ENVB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 49.6 48.2 +1.40 BGMS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $6.0M $6.4M -$440.0K ENVB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BGMS REV ENVB REV BGMS GROSS % ENVB GROSS % BGMS FCF ENVB FCF
FY 2025 $23.6M $24.6M — — -$4.8M -$8.1M
FY 2024 $43.0K $27.0M — — -$8.0M -$7.7M
FY 2023 $71.3M $46.1M — — -$16.1M -$14.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGMS // BETA —
ENVB // BETA —